Clinical Trials
4 trialsNCT02308241 2023-01-05
Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00559091 2022-12-22
Borden-001
Jewish General Hospital
Phase 2 Completed
NCT02959359 2017-08-07
DAA in the Risk of Recurrence After Curative Treatment of HCC
Taipei Veterans General Hospital, Taiwan
Phase 4 Withdrawn
NCT00014391 2010-04-02
Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation
Fred Hutchinson Cancer Center
Phase 3 Completed